{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:16:45Z","timestamp":1772518605095,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.vaccine.2018.02.017","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T10:06:25Z","timestamp":1518170785000},"page":"1345-1352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3"],"prefix":"10.1016","volume":"36","author":[{"given":"Anne-Sophie","family":"Debrie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efc","family":"Coutte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Raze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frits","family":"Mooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Gorringe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Mielcarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Locht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.017_b0005","first-page":"385","article-title":"Pertussis vaccines: WHO position paper","volume":"85","author":"WHO","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2018.02.017_b0010","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMcp041025","article-title":"Clinical practice. Pertussis \u2013 not just for kids","volume":"352","author":"Hewlett","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.02.017_b0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12916-015-0382-8","article-title":"Asymptomatic transmission and the resurgence of Bordetella pertussis","volume":"13","author":"Althouse","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2018.02.017_b0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.12691\/ijcd-3-2-2","article-title":"Potential role of Bordetella pertussis in celiac disease","volume":"3","author":"Rubin","year":"2015","journal-title":"Intl J Celiac Dis"},{"key":"10.1016\/j.vaccine.2018.02.017_b0025","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.imbio.2015.12.008","article-title":"The potential role of subclinical Bordetella pertussis colonization in the etiology or multiple sclerosis","volume":"221","author":"Rubin","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2018.02.017_b0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.imbio.2016.09.017","article-title":"The pertussis hypothesis: Bordetella pertussis colonization in the pathogenesis of Alzheimer\u2019s disease","volume":"222","author":"Rubin","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2018.02.017_b0035","series-title":"Bordetella Molecular Microbiology","first-page":"245","article-title":"Pertussis vaccines","author":"Storsaeter","year":"2007"},{"key":"10.1016\/j.vaccine.2018.02.017_b0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.02.017_b0045","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1371\/journal.ppat.0020065","article-title":"Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough","volume":"2","author":"Mielcarek","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.02.017_b0050","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1128\/CVI.00082-09","article-title":"A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice","volume":"16","author":"Skerry","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.02.017_b0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0008-8749(84)90228-4","article-title":"Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen","volume":"83","author":"Munoz","year":"1984","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2018.02.017_b0060","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1016\/j.vaccine.2008.08.018","article-title":"Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1","volume":"26","author":"Feunou","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.017_b0065","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1016\/j.vaccine.2010.08.017","article-title":"Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1","volume":"28","author":"Feunou","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.017_b0070","doi-asserted-by":"crossref","first-page":"e10178","DOI":"10.1371\/journal.pone.0010178","article-title":"T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice cross protection against parapertussis","volume":"5","author":"Feunou","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.02.017_b0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/CVI.00371-10","article-title":"A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model","volume":"18","author":"Skerry","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.02.017_b0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/infdis\/jix254","article-title":"Live attenuated pertussis vaccine BPZE1 protects baboons against Bordetella pertussis disease and infection","volume":"216","author":"Locht","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.017_b0085","doi-asserted-by":"crossref","first-page":"e83449","DOI":"10.1371\/journal.pone.0083449","article-title":"A phase I clinical study of a live attenuated Bordetella pertussis vaccine \u2013 BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers","volume":"9","author":"Thorstensson","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.02.017_b0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng1227","article-title":"Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica","volume":"35","author":"Parkhill","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2018.02.017_b0095","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3201\/eid1808.120082","article-title":"Population diversity among Bordetella pertussis isolates, United States, 1933\u20132009","volume":"18","author":"Schmidtke","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.017_b0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10096-014-2297-2","article-title":"Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998\u20132012","volume":"34","author":"Van Gent","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.017_b0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0264-410X(89)90193-X","article-title":"Serospecific protection of mice against intranasal infection with Bordetella pertussis","volume":"7","author":"Robinson","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.017_b0110","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1128\/iai.41.3.1138-1143.1983","article-title":"Effect of heptakis(2,6-O-dimethyl)\u00df-cyclodextrin on the production of pertussis toxin by Bordetella pertussis","volume":"41","author":"Imaizumi","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.02.017_b0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-1656(99)00155-8","article-title":"Rational medium design for Bordetella pertussis: basic metabolism","volume":"75","author":"Thalen","year":"1999","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2018.02.017_b0120","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jmb.2005.05.071","article-title":"The periplasmic binding protein of a tripartite tricarboxylate transporter is involved in signal transduction","volume":"351","author":"Antoine","year":"2005","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2018.02.017_b0125","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1128\/iai.62.3.769-778.1994","article-title":"Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis","volume":"62","author":"Menozzi","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.02.017_b0130","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nbt1183-784","article-title":"A broad host range mobilization system for in vivo genetic engineering : transposon mutagenesis in gram negative bacteria","volume":"1","author":"Simon","year":"1983","journal-title":"Bio\/Technology"},{"key":"10.1016\/j.vaccine.2018.02.017_b0135","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3201\/eid1508.081511","article-title":"Bordetella pertussis strains with increased toxin production associated with pertussis resurgence","volume":"15","author":"Mooi","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.017_b0140","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1128\/IAI.66.2.670-675.1998","article-title":"Polymorphism in the Bordetella pertussis virulence factors P.69\/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution","volume":"66","author":"Mooi","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.02.017_b0145","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1128\/CVI.00355-12","article-title":"Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease","volume":"19","author":"Alexander","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.02.017_b0150","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1002\/j.1460-2075.1990.tb07468.x","article-title":"Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation","volume":"9","author":"Willems","year":"1990","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2018.02.017_b0155","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1365-2958.2010.07293.x","article-title":"Novel architectural features of Bordetella pertussis fimbrial subunit promoters and their activation by the global virulence regulator BvgA","volume":"77","author":"Chen","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.017_b0160","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0264-410X(89)90270-3","article-title":"Serotyping Bordetella pertussis strains","volume":"7","author":"Robinson","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.017_b0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1574-695X.2005.00001.x","article-title":"Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies","volume":"46","author":"Rodriguez","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.017_b0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/23744235.2015.1100323","article-title":"Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussis","volume":"48","author":"Guevara","year":"2016","journal-title":"Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.017_b0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S0022172400055546","article-title":"Prevalent serotypes of Bordetella pertussis in non-vaccinated communities","volume":"77","author":"Preston","year":"1976","journal-title":"J Hyg"},{"key":"10.1016\/j.vaccine.2018.02.017_b0180","first-page":"454","article-title":"Vaccination against whooping-cough : relation between protection in children and results of laboratory tests","volume":"2","author":"Medical Research Council","year":"1956","journal-title":"Brit Med J"},{"key":"10.1016\/j.vaccine.2018.02.017_b0185","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1128\/CVI.00355-12","article-title":"Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or pertussis disease","volume":"19","author":"Alexander","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.02.017_b0190","first-page":"61","article-title":"Thirtieth report","volume":"638","author":"WHO Expert committee on biological standartization","year":"1979","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.vaccine.2018.02.017_b0195","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Ad hoc group for the study of pertussis vaccines. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.vaccine.2018.02.017_b0200","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2018.02.017_b0205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1099\/jmm.0.05515-0","article-title":"Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK","volume":"53","author":"Packard","year":"2004","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.017_b0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.meegid.2009.10.007","article-title":"Bordetella pertussis and vaccination : the persistence of a genetically monomorphic pathogen","volume":"10","author":"Mooi","year":"2010","journal-title":"Infect. Genet Evol"},{"key":"10.1016\/j.vaccine.2018.02.017_b0215","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1128\/JCM.42.11.5364-5367.2004","article-title":"Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada","volume":"42","author":"Tsang","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.017_b0220","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0163-4453(80)90650-7","article-title":"Experimental pertussis infection in the rabbit: similarities with infection in primates","volume":"2","author":"Preston","year":"1980","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2018.02.017_b0225","series-title":"Bordetella Molecular Microbiology","first-page":"47","article-title":"The bvg regulon","author":"Stibitz","year":"2007"},{"key":"10.1016\/j.vaccine.2018.02.017_b0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-2836(81)90525-8","article-title":"Genetic and sequences analysis of frameshift mutations induced by ICR-191","volume":"153","author":"Carlos","year":"1981","journal-title":"J Mol Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18301919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18301919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:38Z","timestamp":1759400738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18301919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0264410X18301919"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}